Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...

In the years leading up to its bankruptcy filing, the company also struggled with the growth of free or low-cost ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue ...

The obesity drug price wars are finally starting. After being publicly lambasted for the high cost of their weight-loss shots ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

Founded in 1963 by Jean Nidetch, WeightWatchers began as a weekly weight-loss support group with just 400 attendees. It quickly grew into a global phenomenon, attracting millions of members worldwide ...

GLP-1 analogues, typically prescribed for weight loss, led to a 68% reduction in alcohol intake among regular drinkers.

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Anup Mishra, Chairman, Fortis, CDOC Hospital for Diabetes, and Allied Sciences, Chandrakanth Lahariya, Health and Social Sector Policy Advisor, Preetha Reddy, Executive Vice Chairperson, Apollo ...

The people of Tennessee need access to obesity treatment and interventions to address obesity and allow us to work. While ...